4 research outputs found
From hair to heart: nestin-expressing hair-follicle-associated pluripotent (HAP) stem cells differentiate to beating cardiac muscle cells
<p>We have previously demonstrated that the neural stem-cell marker nestin is expressed in hair follicle stem cells located in the bulge area which are termed hair-follicle-associated pluripotent (HAP) stem cells. HAP stem cells from mouse and human could form spheres in culture, termed hair spheres, which are keratin 15-negative and CD34-positive and could differentiate to neurons, glia, keratinocytes, smooth muscle cells, and melanocytes in vitro. Subsequently, we demonstrated that nestin-expressing stem cells could effect nerve and spinal cord regeneration in mouse models. In the present study, we demonstrated that HAP stem cells differentiated to beating cardiac muscle cells. We separated the mouse vibrissa hair follicle into 3Ā parts (upper, middle, and lower), and suspended each part separately in DMEM containing 10% FBS. All three parts of hair follicle differentiated to beating cardiac muscle cells as well as neurons, glial cells, keratinocytes and smooth muscle cells. The differentiation potential to cardiac muscle is greatest in the upper part of the follicle. The beat rate of the cardiac muscle cells was stimulated by isoproterenol and inhibited by propanolol. HAP stem cells have potential for regenerative medicine for heart disease as well as nerve and spinal cord repair.</p
Heterogeneous cell-cycle behavior in response to UVB irradiation by a population of single cancer cells visualized by time-lapse FUCCI imaging
<p>The present study analyzed the heterogeneous cell-cycle dependence and fate of single cancer cells in a population treated with UVB using a fluorescence ubiquitination-based cell-cycle (FUCCI) imaging system. HeLa cells expressing FUCCI were irradiated by 100 or 200 J/m<sup>2</sup> UVB. Modulation of the cell-cycle and apoptosis were observed by time-lapse confocal microscopy imaging every 30Ā min for 72Ā h. Correlation between cell survival and factors including cell-cycle phase at the time of the irradiation of UVB, mitosis and the G<sub>1</sub>/S transition were analyzed using the KaplanāMeier method along with the log rank test. Time-lapse FUCCI imaging of HeLa cells demonstrated that UVB irradiation induced cell-cycle arrest in S/G<sub>2</sub>/M phase in the majority of the cells. The cells irradiated by 100 or 200 J/m<sup>2</sup> UVB during G<sub>0</sub>/G<sub>1</sub> phase had a higher survival rate than the cells irradiated during S/G<sub>2</sub>/M phase. A minority of cells could escape S/G<sub>2</sub>/M arrest and undergo mitosis which significantly correlated with decreased survival of the cells. In contrast, G<sub>1</sub>/S transition significantly correlated with increased survival of the cells after UVB irradiation. UVB at 200 J/m<sup>2</sup> resulted in a greater number of apoptotic cells.</p
Cancer cells mimic <i>in vivo</i> spatial-temporal cell-cycle phase distribution and chemosensitivity in 3-dimensional GelfoamĀ® histoculture but not 2-dimensional culture as visualized with real-time FUCCI imaging
<p>The phase of the cell cycle can determine whether a cancer cell can respond to a given drug. We previously reported monitoring of real-time cell cycle dynamics of cancer cells throughout a live tumor, intravitally in live mice, using a fluorescence ubiquitination-based cell-cycle indicator (FUCCI). Approximately 90% of cancer cells in the center and 80% of total cells of an established tumor are in G<sub>0</sub>/G<sub>1</sub> phase. Longitudinal real-time imaging demonstrated that cytotoxic agents killed only proliferating cancer cells at the surface and, in contrast, had little effect on quiescent cancer cells, which are the vast majority of an established tumor. Moreover, resistant quiescent cancer cells restarted cycling after cessation of chemotherapy. These results suggested why most drugs currently in clinical use, which target cancer cells in S/G<sub>2</sub>/M, are mostly ineffective on solid tumors. In the present report, we used FUCCI imaging and GelfoamĀ® collagen-sponge-gel histoculture, to demonstrate in real time, that the cell-cycle phase distribution of cancer cells in GelfoamĀ® and <i>in vivo</i> tumors is highly similar, whereby only the surface cells proliferate and interior cells are quiescent in G<sub>0</sub>/G<sub>1</sub>. This is in contrast to 2D culture where most cancer cells cycle. Similarly, the cancer cells responded similarly to toxic chemotherapy in GelfoamĀ® culture as <i>in vivo</i>, and very differently than cancer cells in 2D culture which were much more chemosensitive. GelfoamĀ® culture of FUCCI-expressing cancer cells offers the opportunity to image the cell cycle of cancer cells continuously and to screen for novel effective therapies to target quiescent cells, which are the majority in a tumor and which would have a strong probability to be effective in vivo.</p
Cell-cycle fate-monitoring distinguishes individual chemosensitive and chemoresistant cancer cells in drug-treated heterogeneous populations demonstrated by real-time FUCCI imaging
<p>Essentially every population of cancer cells within a tumor is heterogeneous, especially with regard to chemosensitivity and resistance. In the present study, we utilized the fluorescence ubiquitination-based cell cycle indicator (FUCCI) imaging system to investigate the correlation between cell-cycle behavior and apoptosis after treatment of cancer cells with chemotherapeutic drugs. HeLa cells expressing FUCCI were treated with doxorubicin (DOX) (5Ā Ī¼M) or cisplatinum (CDDP) (5Ā Ī¼M) for 3Ā h. Cell-cycle progression and apoptosis were monitored by time-lapse FUCCI imaging for 72Ā h. Time-lapse FUCCI imaging demonstrated that both DOX and CDDP could induce cell cycle arrest in S/G<sub>2</sub>/M in almost all the cells, but a subpopulation of the cells could escape the block and undergo mitosis. The subpopulation which went through mitosis subsequently underwent apoptosis, while the cells arrested in S/G<sub>2</sub>/M survived. The present results demonstrate that chemoresistant cells can be readily identified in a heterogeneous population of cancer cells by S/G<sub>2</sub>/M arrest, which can serve in future studies as a visible target for novel agents that kill cell-cycle-arrested cells.</p